|
THIS IS A TRUE STORY:
ONE OF OUR FEMALE CLIENTS WAS WORKING HARD TO LOSE WEIGHT FROM HER HIPS, BUTT, AND THIGHS. HER EFFORTS DID NOT REFLECT ANY NOTICABLE CHANGES SO SHE ASKED FOR HELP.
THE FIRST THING WE DID WAS VERIFY HORMONAL IMBALANCES. THE SKIN FOLD READING INDICATED THAT SHE WAS ESTROGEN-DOMINANT AND HAVING A HARD TIME MANAGING HER INSULIN.
IN THE SCREENING PROCESS, SHE INDICATED TO OUR STAFF THAT HER FAMILY HAD A HISTORY OF BREAST CANCER. WHENEVER A FEMALE CLIENT IS ESTROGEN-DOMINANT AND HAS A GENETIC CONNECTION TO ESTROGEN-SENSITIVE DISEASES, WE STRONGLY SUGGEST A TEST TO VERIFY IF THERE IS AN INCREASED CHANCE OF DEVELOPING BREAST, UTERINE, AND OTHER ESTROGEN-RELATED CANCERS.
THE CLIENT HAD THE TEST DONE. THE RESULTS INDICATED THAT HER 2/16 RATIO (2-HYDROXYESTRONE AND 16-ALPHA-HYDROXYESTRONE) WAS NOT HIGH ENOUGH TO LOWER THE RISK OF DEVELOPING ESTROGEN-SENSITIVE DISEASES.
FORTUNATELY FOR HER, STUDIES HAVE PROVEN THAT DIETARY AND SUPPLEMENTAL INTERVENTION CAN SIGNIFICANTLY INCREASE THE 2/16 ALPHA RATIO.
THE GOOD NEWS IS THAT OUR CLIENT HAS SUCCESSFULLY RAISED HER 2/16 RATIO HIGH ENOUGH TO LOWER HER RISK OF DEVELOPING ESTROGEN-SENSITIVE CANCERS.
FOR MORE INFORMATION, CALL OUR OFFICE FOR AN IN-DEPTH HEALTH CONSULTATION.
Internet References:
http://ehp.niehs.nih.gov/docs/1997/Suppl-3/ursin.html
http://www.renewalresearch.com/articles.php/22
http://www.tahoma-clinic.com/hrtbreastcancer.shtml
| 
